{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:26:08Z","timestamp":1691727968398},"reference-count":26,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2023.2658","type":"journal-article","created":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T07:56:23Z","timestamp":1687938983000},"source":"Crossref","is-referenced-by-count":0,"title":["Differential diagnoses and the mutational landscape of myelodysplastic\/myeloproliferative neoplasm with neutrophilia: A case report"],"prefix":"10.3892","volume":"19","author":[{"given":"Bernhard","family":"Strasser","sequence":"first","affiliation":[{"name":"Institute of Laboratory Medicine, Hospital Wels\u2011Grieskirchen, A-4600 Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Gr\u00fcnberger","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Hospital Wels\u2011Grieskirchen, A-4600 Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Steindl","sequence":"additional","affiliation":[{"name":"Department of Molecular Biology, Hospital Wels\u2011Grieskirchen, A-4600 Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Heibl","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Hospital Wels\u2011Grieskirchen, A-4600 Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josef","family":"Thaler","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine IV, Hospital Wels\u2011Grieskirchen, A-4600 Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Haushofer","sequence":"additional","affiliation":[{"name":"Institute of Laboratory Medicine, Hospital Wels\u2011Grieskirchen, A-4600 Wels, Austria"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2023,6,28]]},"reference":[{"key":"key20230810121450_b1-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic\/Dendritic Neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"key":"key20230810121450_b2-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1080\/10428194.2017.1357179","article-title":"Myelodysplastic and myeloproliferative neoplasms: Updates on the overlap syndromes","volume":"59","author":"Thota","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"key20230810121450_b3-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1515\/cclm-2018-0979","article-title":"Improvement in detecting sepsis using leukocyte cell population data (CPD)","volume":"57","author":"Urrechaga","year":"2019","journal-title":"Clin Chem Lab Med"},{"key":"key20230810121450_b4-MCO-19-2-02658","first-page":"13","article-title":"Measurement of total lactate dehydrogenase activity","volume":"15","author":"Vanderlinde","year":"1985","journal-title":"Ann Clin Lab Sci"},{"key":"key20230810121450_b5-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/ijlh.12212","article-title":"Leukocytosis","volume":"36","author":"Chabot-Richards","year":"2014","journal-title":"Int J Lab Hematol"},{"key":"key20230810121450_b6-MCO-19-2-02658","first-page":"1004","article-title":"Evaluation of patients with leukocytosis","volume":"92","author":"Riley","year":"2015","journal-title":"Am Fam Physician"},{"issue":"102521","key":"key20230810121450_b7-MCO-19-2-02658","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcmd.2020.102521","article-title":"Can absolute basophilia distinguish e1a2 BCR-ABL1 chronic myeloid leukemia from chronic myelomonocytic leukemia?","volume":"87","author":"Langabeer","year":"2021","journal-title":"Blood Cells Mol Dis"},{"key":"key20230810121450_b8-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"177","DOI":"10.2217\/fon-2017-0334","article-title":"Atypical chronic myeloid leukemia: A rare entity with management challenges","volume":"14","author":"Dhakal","year":"2018","journal-title":"Future Oncol"},{"key":"key20230810121450_b9-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/10428190009148850","article-title":"Bone marrow features and clinical findings in chronic myeloid leukemia-a comparative, multicenter, immunohistological and morphometric study on 614 patients","volume":"36","author":"Thiele","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"key20230810121450_b10-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/ijlh.13607","article-title":"How I investigate dysgranulopoiesis","volume":"43","author":"Shekhar","year":"2021","journal-title":"Int J Lab Hematol"},{"key":"key20230810121450_b11-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1182\/asheducation-2015.1.264","article-title":"What's different about atypical CML and chronic neutrophilic leukemia?","volume":"2015","author":"Dao","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"6862","key":"key20230810121450_b12-MCO-19-2-02658","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186862","article-title":"Atypical chronic myeloid leukemia: Where are we now?","volume":"21","author":"Crisa","year":"2020","journal-title":"Int J Mol Sci"},{"key":"key20230810121450_b13-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/leu.2013.133","article-title":"SETBP1 mutations occur in 9% of MDS\/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations","volume":"27","author":"Meggendorfer","year":"2013","journal-title":"Leukemia"},{"key":"key20230810121450_b14-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"e244","DOI":"10.3324\/haematol.2014.113159","article-title":"Specific molecular mutation patterns delineate chronic neutrophilic leukemia, atypical chronic myeloid leukemia, and chronic myelomonocytic leukemia","volume":"99","author":"Meggendorfer","year":"2014","journal-title":"Haematologica"},{"key":"key20230810121450_b15-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1182\/blood-2014-06-579466","article-title":"Recurrent ETNK1 mutations in atypical chronic myeloid leukemia","volume":"125","author":"Gambacorti-Passerini","year":"2015","journal-title":"Blood"},{"key":"key20230810121450_b16-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1038\/ng.2495","article-title":"Recurrent SETBP1 mutations in atypical chronic myeloid leukemia","volume":"45","author":"Piazza","year":"2013","journal-title":"Nat Genet"},{"key":"key20230810121450_b17-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1056\/NEJMoa1214514","article-title":"Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML","volume":"368","author":"Maxson","year":"2013","journal-title":"N Engl J Med"},{"key":"key20230810121450_b18-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1182\/blood-2014-02-553800","article-title":"Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic\/myeloproliferative neoplasms","volume":"123","author":"Wang","year":"2014","journal-title":"Blood"},{"key":"key20230810121450_b19-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1182\/blood.2019000611","article-title":"Genomic landscape of neutrophilic leukemias of ambiguous diagnosis","volume":"134","author":"Zhang","year":"2019","journal-title":"Blood"},{"key":"key20230810121450_b20-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.1002\/cncr.33622","article-title":"Clinicopathologic correlates and natural history of atypical chronic myeloid leukemia","volume":"127","author":"Montalban-Bravo","year":"2021","journal-title":"Cancer"},{"key":"key20230810121450_b21-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ajh.24722","article-title":"Targeted next generation sequencing and identification of risk factors in World Health Organization defined atypical chronic myeloid leukemia","volume":"92","author":"Patnaik","year":"2017","journal-title":"Am J Hematol"},{"issue":"131","key":"key20230810121450_b22-MCO-19-2-02658","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0815-5","article-title":"Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: A position paper","volume":"12","author":"Soverini","year":"2019","journal-title":"J Hematol Oncol"},{"key":"key20230810121450_b23-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood-2013-05-500959","article-title":"The new genetics of chronic neutrophilic leukemia and atypical CML: Implications for diagnosis and treatment","volume":"122","author":"Gotlib","year":"2013","journal-title":"Blood"},{"key":"key20230810121450_b24-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: Integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"key20230810121450_b25-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcmd.2016.03.003","article-title":"Clinical features of JAK2V617F- or CALR-mutated essential thrombocythemia and primary myelofibrosis","volume":"60","author":"Monte-Mor Bda","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"key20230810121450_b26-MCO-19-2-02658","doi-asserted-by":"publisher","first-page":"S101","DOI":"10.1016\/S2152-2650(20)30477-8","article-title":"Update on CML-Like Disorders","volume":"20 (Suppl 1)","author":"Cross","year":"2020","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T09:15:22Z","timestamp":1691658922000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2023.2658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,28]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,6,28]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2023.2658","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,28]]},"article-number":"62"}}